Episode Details

Back to Episodes
CC Pharm | Nitroprusside

CC Pharm | Nitroprusside

Season 7 Published 6 days, 5 hours ago
Description

Sodium nitroprusside is an ultra-potent, direct-acting peripheral vasodilator characterized by rapid hemodynamic action and highly toxic metabolites. This 80/20 summary distills its essential clinical, pharmacological, and nursing guidelines:

1. Mechanism & Hemodynamic Effects

  • Mechanism: Direct action on arterial and venous smooth muscle; myocardial contractility is unaffected.
  • Hypertension: Reduces afterload and causes venous pooling, decreasing arteriolar resistance.
  • Heart Failure: Improves left ventricular performance, increasing cardiac index, cardiac output, and stroke volume while slowing heart rate.

2. Dosing & Clinical Administration

  • Onset & Duration: Rapid onset (1-2 mins); effects persist for 1-10 mins after discontinuation.
  • Titration: Confirm drug effect for 5 minutes before titrating to a higher dose.
  • Dosing (Adults):
    • Hypertensive Emergency: Start 0.3-0.5 mcg/kg/min; titrate by 0.5 mcg/kg/min every 5 mins. Max: 10 mcg/kg/min for 10 mins.
    • Acute Heart Failure: Start 0.1-0.3 mcg/kg/min. Max: 10 mcg/kg/min (doses >400 mcg/min have no added benefit).
    • Mitral Regurgitation: Start 15 mcg/min, titrate every 2 mins to reduce mean arterial pressure by 10-20 mmHg.
  • Preparation & Administration:
    • Dilute 50 mg in 250–1000 mL of 5% Dextrose (D5W). Never give direct IV injection.
    • Solution is clear, colorless to red/brown; discard if blue, green, or bright red.
    • Protect from light during administration with an opaque sleeve.
    • Do not run other drugs in the same solution.

3. Boxed Warning: Cyanide & Thiocyanate Toxicity

  • Cyanide Toxicity: Metabolism produces dose-related cyanide.
    • Doses >2 mcg/kg/min exceed normal clearance. Buffering is exceeded in <1 hour at the max 10 mcg/kg/min rate.
    • Action: Discontinue and consider sodium nitrite and sodium thiosulfate.
  • Thiocyanate Toxicity: Cyanide converts to thiocyanate via mitochondrial rhodanase (renal half-life: 3 days).
    • Life-threatening at 200 mg/L. Monitor plasma levels if cumulative doses exceed 7 mg/kg/day.
  • Organ Impairment Risk:
    • Hepatic disease: High susceptibility to cyanide toxicity.
    • Renal Impairment: eGFR <30: limit mean infusion to <3 mcg/kg/min (Anuria: limit to 1 mcg/kg/min).

4. Nursing Interventions

  • Monitoring: Mandatory continuous blood pressure monitoring, preferably via an intraarterial pressure sensor. Monitor urine output in heart failure.
  • Safety: Use a volumetric infusion pump. Watch for hypotension, methemoglobinemia, bradycardia, or metabolic acidosis.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us